To assess, in the Im11ltlll fIId011letricll ccll firle HEC-1-A, the presencc if proteill tyrosine phosphatase ID (PTP1D) and thc possible regulation of its IIIRNA expressioll by mitogcrls slIch as forskolil1 (atl a.'(e/lt that increases intracellular cyclic adenosine monophosphate [cAlI.JP/ levels), epidcmwl ,((rowth factor (EGF), alld insuli11-likc growth fa .
" cvtosolic and transmembrane proteins that participate in the delicate balance of tyrosine phosphorylation! dephmphorylation and thus play a role in the re!,rulation of cdl b'Towth, development, and differentiation. Some of these PTPascs act to enhance transduction of signals from receptor tyrosine kinases to the nucleus, whereas others act in a negative rq,rulatory role. I . 2 One such enzyme, protein tyrosine phosphatase ID (PTP1D; also known as Syp, SHPTP2, SHPTP3, and PTP2C), is a ubiquitously expressed cytosolic PTPase that contains twO Src homology (SH2) domains at its amino terminus JA These domains have been shown to associate with the cytoplasmic domains of the epidermal growth factor (EGF), insulin-like !,'Towth tactor-I (IGf-I), and platelet-derived b'Towth factor receptors,,·4 as well as \vith the intemJediate signaling protein, insulin receptor substrate-l (IRS-l)." In addition, the activity of PTP1 D has been shown to be ligand Ct\pyrip;ht It;, tt)l)7 by the Soci<..,t)' filr CYlllTulu~j ( [mt''\[lg,uioll. Pub;j,h(.·J by El .. e ... it'r S':lcncl' lrH:. dependent, requiring phosphorylation of tyrosine residues after autophosphorylation of tyrosine kinase receptors. 4 Although the role of this PTPase in signal transduction is not understood completely, microinjection of anti-PTP1D antibody and GST -SH2 fusion protein into mouse fibroblasts after stimulation with EGf and IGf-I has demonstrated decreased mitogene,is f , Thus, its rolc appears to be positive in the signaling cascade after receptor tyrosine kinase activation.
Previous work from our laboratory has shO\vn that peptide growth factors and substances that increase intracellular cyclic adenosine monophosphate (cAMP) levels produce mitogenesis in the endometrial cell line HEC_l_A.7.H Because growth and proliferation of I IEC-l-A cells are stimulated by torskolin (an agent that stimulates intracellular cAMP levels), EGF, and IGF-I by tyrosine phosphorylation, the present studies were conducted to exallline whether. in endometrial carcinoma. PTP1 D mRNA expression is positively linked to the increase in proliferative actiVIty stimulated by EGF, IGf-I, and forskolin (cAMP). Our results show that all three mitogens stimulate the expression of PT!>l D mRNA in the endometrial adenocarcinoma cell line HEC-1-A.
Regulation of PTP I D in the Cell Line HEC-I-A

MATERIALS AND METHODS
Cell Line Culture and Treatment
The HEC-I-A (HTB-112) cell line "vas purchased from the American Type Culture Collection (Rockville, MD). The cells were cultured in 75-cm 3 flasks (Becton Dickinson, Lincoln Park, NJ) and maintained in Phenol red-free Dulbecco's modified Eagle's medium/Ham's nutrient mixture F12 (DME/F12; Sih'lTla, St. Louis, MO) supplemented with 10% fetal bovine serum (FBS), 1.2 g sodium bicarbonate, 50 /l-glrnL gentamicin, and 2 U/mL nystatin. The culture medium was adjusted to pH 7.35 before filtration (Nalgene, Rochester, NY). Cultures were maintained under sterile conditions at 37C in a humidified environment containing 5% CO 2 , For experiments, the cells were detached with fresh trypsin (0.02%)/ ethylenediaminetetra-acetic acid for 10 minutes. Fresh medium was added and the cell suspension was centrifuged at 150 X g for 10 minutes. The supernatant was discarded and the cell pellet was rcsuspended in fresh medium. Cells were dispensed into tOO-mm tissue culture dishes (Recton Dickinson) and were grown to confluence. When the effect of test substances was examined, the cells were preincubated for 24 hours in DME/FI2 supplemented with D.3% bovine serum albumin (BSA). 50 jJ..g gentamicin, and 2 U/ml nystatin. Stock solutions were made of EGF and forskolin (Sigma) and IGF-I (a gift iTom the Eli liIly Research laboratories, Indianapolis, IN), and aliquots were added to the cultured cells. All experiments were repeated at least three times. and representative results from a single experiment are presented.
RNA Extraction. Northern Blot. and Hybridization
Total RKA was extracted using the procedure ofChomczynski and Sacchi.'J Briefly, 2 molll sodium acetate, pH 4.0, was added to celllysates and extracted with water-saturated phenol and chlorofon1J:isoamyl alcohol (49:1). RNA was precipitated with one volume of isopropyl alcohol and was quantified spectrophotometrically. Total RNA \vas separated by electrophoresis in a 1.2'1<, agarose gel containing 3% fonnaldehyde, blotted to a nitrocellulose membrane (Millipore, Bedford. MA) using lOX standard saline citrate (SSC). pH 7.ll. and ultraviolet-erosslinked with 12 mJ in a UV -Stratalinker (Stratagene, la Jo1l3. CA).TtI Northern blots were prehybridized in a solutIOn containing 1 X Dcnhardt's, 10 mL 2()X saline sodium phosphate ethylenediaminetetra-acetic acid. 20 ml deionized formamide, and lOO jJ..g/mL salmon sperm DNA. at room temperature, and once with 0.1 X SSC at 50C for 00 minutes. The blots were exposed to Kodak XAR film at -80C for 4 days. In a similar fashion. all blots were stripped by riming in boiling water for 15 minutes and were hybridized with a 1.0-kb i3-actin cDNA probe. AutoradiograJ1l, were scanne:d (Sca~et lIC; Hewlett Packard, Palo Alto, CA) using an NIH viewer program (Shareware; National Institutes of Health), and bands were quantified in arbitrary demitoJ1letric units.
RESULTS
Initial expe:rimenrs were: conducted to de:termine the expression of PTPl D in the endometrial carcinoma cell line HEel-A under basal conditions. Cells were grown to confluence in a WO-mm dish with DME/F12 and 10% FBS. Cells were serum-starved tor 24 hours and total RNA was extracted, separated on an agarose gel, and hybridized with the: PT}>1 D probe as described earlier. The purpose of preincubation in serum-free medium was to exclude the possible stimulatory effect of growth factors associated with the senun to determine "vhether PT!'1 D was expressed under basal conditions. Figure  1 de:monstrates the presence of a 6.8-kb transcript in this endometrial carcinoma cdl line, which corresponds to PT]>1 D mRNA.J After establishing the expression of PTPl D mRNA, we conducted !1.1rther experiments to detennine whether growth factors are capable of regulating PT]>1 n mRNA exprcs,ion in endometrial carcinoma. For time-course studies, HEC-l-A cells were subculrured in five 1 O()-mm tissue culture dishes and grown to confluence. After 24 hours of preincubation, the media were replaced with fresh, serum-free media. rorskolin Time (hours) Figure 2 . Effects of time of exposure ofEGF on PTPID mRNA expression. HEC-I-A cells were grown to confluence in lOO-mm culture dishes and were serum starved for 24 hours. Media were replaced with frt-sh DME/F12 containing 0.3% BSA, and EGF was added (final concentration 10 ng/mL) and incubated for 24 hours. Cells were harvested at intervals of 0, 1, 3, 6, and 24 hours, total RNA was extracted. and Northern hybridization was perfornu:d by using PTPID cDNA probe. Hybridization bands were quantified from autoradiograms in densitometric units and were nonnalized to actin. The ordinate represents the ratio of PTPl D mRNA to actin mRNA. PTPl D = protein tyrosine phosphatase 1 D.
was added to four tissue culture dishes to a final concentration of 10 jJ.mol/L. Cells were lysed, and total RNA was extracted at 0, 1. 3, 6, and 24 hours after treatment with forskolin. Similar experiments were perfonned with EGF (10 ng/mL). baseline by 24 hours. The peak PTPID mRNA response occurred at 3-6 hours for both EGF and IGF-L To characterize further the regulation of PTPlD mRNA expression in this endometrial carcinoma, we subcultured HEC-I-A cells in a series of six 100-n1ln tissue culture dishes, grew them to confluence, and incubated them with increasing doses (1, 5, to, 20, and 30 ~mollL) offorskolin for 6 hours.
Total RNA was extracted, and Northern blots were perfornled 1 2 3 4 5 PTPl·D Actin Figure 3 . Effects oftirne of exposure oflGF-1 on PTP1D mRNA expression. HEC-l-A cells were grown to confluence in lOO-nUll culture dishes and were serum starved for 24 hours. Media were replaced with fresh DME/F12 containing 0.3% BSA, and IGF-I was added (final concentration 100 n~imL) and incubated for 24 hours. Cells were harvested at intervals of 0, 1, 3. 6. and 24 hours. total RNA was extracted. and Nonhern hybridization was perfornled by using PTPID cDNA probe. Hybridiation bands were yuantiiied from autoradiob'Tams in dcn-,irometric units and were nonnalized to actin. The ordinate represents the ratio ofPTPlD mRNA to actin rnRNA. Abbreviation as in Figure 2 . PTPl-D Actin Figure 4 . Effects of time of exposure of forskolin on PTPl D mRNA expression. HEC-\-A cells were grown to confluence in lOO-mm culture dishes and were serum starved for 24 hours. Media were replaced \vith fresh DME/F12 containing 0.3% BSA, and forskolin was added (final concentration 10 J.l.moIlL) and incubated for 24 hours. Cells were harvested at intervals of 0, 1,3,6, and 24 hours, total RNA was extracted, and Northern hybridization was performed by using PTP1D cDNA probe. Hybridization bands were quantified from autoradiograms in densitometric units and were normalized to actin. The ordinate represents the ratio ofPTP1D mRNA to actin mRNA. Abbreviation as in Figure 2 .
Regulation of PTPID in the Cell line HEC-I-
using a [ 32 PJ-labeled PTPID cDNA probe. Figure 5 demonstrates that the effect of forskolin on PTP1 D mRNA expression was dose dependent. The dose responses of EGF and IGF-I were not tested because our previous studies 7 • B showed that the selected doses of these growth factors stimulate mitogenesis of HEC-I-A cells.
DISCUSSION
PTPID is a nonmembrane, protein tyrosine phosphatase ,that contains two SH2 domains. PTPID, also known as SHPTP2, Syp, PTP2C, and SHPTP3, is a ubiquitously expressed protein that is homologous to the Drosophila gene product corhcn:w (C5W). 12 In mammalian cells, the gene encodes a 6.8-kb message, v,'hich in turn translates into a 68-kDa protein,2-4 the full function of which is still being elucidated. However, recent work has shown that PTP! D is a positive mediator of growth Do.et (uM) 30 factor-;;timulated mitogenesis/' serving as an adapter between receptor tyrosine kinases and the Grb-SOS complex. 12 . 13 In previous studies from our laboratory, we established that EGf, the IGFs, insulin, and forskolin stimulate mitogenic activity of the human endometrial cancer cells HEC-I-A and KLE?,H In our effort to understand how the growth of endometrial carcinoma may be regulated by these growth factors, we examined the expression and inducibility of PTPID in response to EGF, IGF-I, and forskolin in HEC-l-A cells.
Our studies show that the endometrial carcinoma cell line HEC-I-A expresses PTPID mRNA with a transcript size comparable to that reported in other cell types. 2 -4 The expression of PTPID mRNA transcript was induced by EGF, IGF-I, and forskolin in a time-dependent manner. The induction of the mRNA transcript in response to EGF, IGF-I, and forskolin occurred at concentrations that have been shown to 1 2 3 4 5 6 Figure 5 . Effects of dose offorskolin on PTP1D mRNA expression. HEC-I-A cells were grown to contluence in lOO-mm culture dishes and were serum starved for 24 hours. Media were replaced with fresh DME/fl2 containing 0.3% BSA, and forskolin was added to a final concentration of I, 5, 10, 20, or 30 fLmollL and incubated for 6 hours. Cells were harvested, total RNA was extracted, and Northern hybridization was perfornled by using PTP1 D cDNA probe. Hybridization ba:lds were quantified from autoradiograms in densitomctric units and were· nonnalized to actin. The ordinate represents the ratio of PTP1D mRNA to actin mRNA. Abbreviation as in Figure 2 . 314 J Soc Gynecol Invest Vol. 4, No. 6, Nov.!Dec. 1997 stimulate mitogenesis. 7 • H Although we have not detennined whether the effect of these stimulatory agents on PTPID mRNA is due to increased gene expression or decreased degradation of the transcript, the present studies implicate PTPl D as a probable intemlediate in growth factor-mediated mitogenesis.
PTPI-D Actin
During hyperplasia and carcinogenesis, the proliferative and differentiating activity of the endometrium becomes deregulated and endometrial cells progress to stages of rapid growth, immortalization, invasiveness, metastasis, and angiogenesis. Insulin-like growth factor-I, a tyrosine kinase receptor, has been shown to be a key factor involved in the phenotypic transformation of various cell types. Sell et al 14 showed that simian virus 40 large antigen was unable to transfoml mouse embryonic fibroblasts that lacked the IGF-I receptor. Similarly, the ability of the IGF-I receptor to facilitate the transfOnlling capacity of the EGF receptor was demonstrated in wild-type mouse embryo cells. Coppola et al 15 showed that when the EGF receptor expression plasmid was overexpressed in cells derived from Iittermate embryos that had the IGF-I receptor genes disrupted, those cells wefe resistant to transformation despite reintroduction of the wild-type IGF-I receptor. Other studies fTOm om laboratory have further demonstrated that the IGF-I rcceptor is highly expressed in neoplastic endometrium. 16 The current studies also support the hypothesis that signaling path\vays arc not isolated from each other, but converge to produce" crosstalk" and activate a series of events that result in cell proliferation and possibly malignancy. Our laboratory has shown that the mitogenic response of the endometrial adenocarcinoma cell line HEC-1-A to IGF-I is enhanced whcn the cells arc preincubated with agents that increase intracellular cAMP.H Other studies I7 -1 '; have shown that pmstaglandins increase cAMP accumulation in endometrial cells. Thus, the effects ofEGF and IGF-I in endometrial cell proliferation, and possibly in malignant transformation, could be enhanced by prostaglandins in vivo.
Insulin-like b'Towth factor receptor substrate I has been identified in different cell types 20 -22 as the mediator of IGF-I action. One likely mechanism by which IRS-J phosphorylation is enhanced may involve the action of protcin tyrosine phosphatases (PTl'ases). Studies by Kuhne ct al s and Milarski and Saltiel,1.1 have shown that upon activation of insulin reccptor, IRS-I undergoes phosphorylation at multiple tyrosine residues and forms a complex with PTPl D. The lRS-1! PTPI D complex further associates with Grb-SOS, leading to the activation of ras-mediated mitogen-activated extracellular signal regulated protein kinase kinase (mitogen-activated protein kinase kinase) phosphorylation, culminating in mitogenesis. Similarly, Xiao et aIr. and Rivard ct al2.1 have shown that when PTPI D is blocked hy either an anti-Syp antibody or an inactive GST -SH2 protein, fibroblasts that haw been serum starved and then stimulated with EGF fail to proliferate.
The site of action of PTPl D in mitogenic signaling is not completely understood. Studies by Milarski and Saltiel U show cd that expression of a catalytically inactive mutant of PTP1 D completely blocked stimulation of the MA I' kinase Burke et al pathway by insulin as well as insulin-induced mitogenesis. Tyrosine phosphorylation of the insulin receptor, or tyrosine phosphorylation of IRS-I or She, was not affccted by the expression of the dominant negative PTP1 D.Ll Evidence also suggests that catalytically inactive PTP 1 D does not interfere with the binding of Grb2 to IRS-l or fOnllation of the Shc-Grb2 complex.:!4 These studies suggest that PTPID acts downstrt'am of initial phosphorylation leading to ras activation, upstream of MAP kinase. Further studies by Sawada et aJ2~ have show'n that catalytically incrt PTPl D blocked activation of both MEK and raf-l kinase by insulin, suggesting that PTPl D might exert its growth-promoting effect by acting at a step downstream of p21 "". On the basis of our studies, we conclude that the mitogenic stimulation of HEC-l-A cells by EGF, IGF-I, and forskolin may be mediated by induction of PTP1 D. PTPl I), in turn, may exert its effect on mitogenesis by acting at a step either upstream or downstream of p21 T"'.
Our studies suggest that PTP1D may play a cnlcial role in the mitogenic stimulation of HEC-1-A cells by EGF, IGF-I, and forskolin. The finding that PTPl D mRNA JIlay be induced by forskolin is a novel observation not described previously. Although the involvement of PTPID in the mitogenic signaling pathways of EGF and IGF-I in this endometrial carcinoma cell line needs to be substantiated with further experimental work, its inducibility by these peptide growth factors and substances that increase intracellular cAMP levels further supports its involvement in mitogenesis. Further evaluation of PTPl D is necessary to elucidate its precise function in the malignant trallSiormatioIl of endometrial cells.
